EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy

Atsushi Musha iD, Nobuteru Kubo iD, Hidemasa Kawamura iD, Naoko Okano iD, Hiro Sato iD, Kohei Okada, Kento Tomizawa, Norichika Ota, Akiko Adachi, Masato Shino, Osamu Nikkuni, Shota Ida und 5 weitere

Cancer Reports · 2023

DOI: 10.1002/cnr2.1825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2023. Verfasst von Atsushi Musha und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gunma University Heavy Ion Medical Center, Maebashi, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Melanoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Uehara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbon‐ion radiotherapy (C‐ion RT) is effective for head and neck mucosal melanoma (HN‐MM), including radioresistant mucosal melanoma. Melanoma also responds effectively to immune checkpoint inhibitors (ICIs). Data on the efficacy and safety of ICIs for HN‐MM are insufficient.

Aims

To analyze the efficacy and safety of ICI salvage therapy in patients with HN‐MM recurrence after C‐ion RT. Methods and Results This retrospective study analyzed the medical records of 52 patients with HN‐MM treated with C‐ion RT between 2012 and 2020. A dose of 57.6 or 64.0 Gy (relative biological effectiveness) was provided in 16 fractions. The primary endpoint was 3‐year overall survival (OS) rate. The median follow‐up time was 26.8 months for all patients. A total of 29 patients had local recurrence or distant metastasis, and 16 patients who received ICI therapy. The 3‐year OS rate in the ICI group ( n = 16) and best supportive care group ( n = 13) were 53.8% and 0.0%, respectively ( p = 0.837); the difference was not statistically significant. There were no deaths after 1 year among patients who underwent ICI therapy. No adverse events associated with C‐ion RT were related to or exacerbated by ICI.

Conclusion

ICI salvage therapy is effective and safe for patients with HN‐MM recurrence after C‐ion RT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsMelanomaHumansImmune Checkpoint InhibitorsRetrospective StudiesCarbon

Stichwörter der Autor:innen

chemotherapymelanomaradiotherapysurvival

Substanzen

Immune Checkpoint InhibitorsCarbon

Autor:innen und Institutionen

  • Gunma University Heavy Ion Medical Center, Maebashi, Japan.
  • Department of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Maebashi, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Radiology, Jichi Medical University Hospital, Tochigi, Japan.
  • Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, University of Toyama, Toyama, Japan.

ORCID-Profile: Atsushi Musha, Nobuteru Kubo, Hidemasa Kawamura, Naoko Okano, Hiro Sato, Jun-Ichi Saitoh

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Uehara Memorial Foundation

Zitieren

APA

Musha, A., Kubo, N., Kawamura, H., Okano, N., Sato, H., Okada, K., Tomizawa, K., Ota, N., Adachi, A., Shino, M., Nikkuni, O., Ida, S., Shirai, K., Saitoh, J. I., Yokoo, S., Chikamatsu, K., & Ohno, T. (2023). Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy. Cancer Reports. https://doi.org/10.1002/cnr2.1825

Vancouver

Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, et al. Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy. Cancer Reports. 2023. doi:10.1002/cnr2.1825

BibTeX
@article{Musha2023,
  author = {Musha, Atsushi and Kubo, Nobuteru and Kawamura, Hidemasa and Okano, Naoko and Sato, Hiro and Okada, Kohei and Tomizawa, Kento and Ota, Norichika and Adachi, Akiko and Shino, Masato and Nikkuni, Osamu and Ida, Shota and Shirai, Katsuyuki and Saitoh, Jun-Ichi and Yokoo, Satoshi and Chikamatsu, Kazuaki and Ohno, Tatsuya},
  title = {Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy},
  journal = {Cancer Reports},
  year = {2023},
  doi = {10.1002/cnr2.1825}
}
Kostenlos starten →